Skip to main content

Table 2 Distribution of the administered CT and response rates among patients

From: Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer

 

Response

N

%

First line chemotherapy

A-CT

no

25

48,1%

yes

27

51,9%

NA/NT-CT

no

14

66,7%

yes

7

33,3%

T-CT

no

11

78,6%

yes

3

21,4%

Second line chemotherapy

A-CT

no

10

71,4%

yes

4

28,6%

NA/NT-CT

no

20

87,0%

yes

2

8,7%

T-CT

no

17

68,0%

yes

8

32,0%

  1. Abbreviations: A-CT anthracycline containing chemotherapy, NA/NT-CT non-anthracyline/non-taxane containing chemotherapy, T-CT taxane containing chemotherapy